Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting
Graefe's Archive for Clinical and Experimental Ophthalmology Oct 20, 2017
Giocanti-Auregan A, et al. - This research incorporated an analysis of the sustained intraocular pressure (IOP) elevation after repeated anti-VEGF intravitreal injections (IVI) in patients with diabetic macular edema (DME). It was ascertained that in eyes with center-involved DME without prior glaucoma or IOP elevation, repeated anti-VEGF IVI could raise the risk of sustained IOP elevation in about 7% of eyes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
